REQUEST A DEMO
Total
USD $0.00
Search more companies

James Brown Pharma C.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: James Brown Pharma C.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

james brown pharma c.a is a pharmaceutical company that offers a wide range of pharmaceutical products for human and animal health, including oral and injectable tablets, aerosols, creams, oral solutions, soluble powders, and soft gel capsules. They also provide manufacturing services for various types of products in different dosage forms. In 2009, the company launched its own line of dog food called MASCOTA JB and formed a strategic alliance with MARS Andino of Colombia for importing and distributing pet care brands. Additionally, james brown pharma c.a is a pioneer in the manufacturing of liquid gelatin capsules (softgel) and has innovated its ERP system with SAP Business One.

Headquarters
Av Interoceanica Km 23 1/2, Edificio Bldg.
Quito; Pichincha;

Contact Details: Purchase the James Brown Pharma C.A. report to view the information.

Website: http://www.jamesbrownpharma.com

Basic Information
Total Employees:
Purchase the James Brown Pharma C.A. report to view the information.
Outstanding Shares:
Purchase the James Brown Pharma C.A. report to view the information.
Registered Capital:
Purchase the James Brown Pharma C.A. report to view the information.
Incorporation Date:
August 13, 1980
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
29.12%
Purchase this report to view the information.
27.8%
Purchase this report to view the information.
23.86%
Purchase this report to view the information.
10.61%
Purchase this report to view the information.
3.68%
Company Performance
Financial values in the chart are available after James Brown Pharma C.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
21.88%
Total operating revenue
20.66%
Operating profit (EBIT)
-79.09%
EBITDA
-72.7%
Net Profit (Loss) for the Period
-4.77%
Total assets
10.86%
Total equity
11.48%
Operating Profit Margin (ROS)
-64.62%
Net Profit Margin
-2.12%
Return on Equity (ROE)
-2.12%
Debt to Equity Ratio
10.51%
Quick Ratio
-0.09%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?